Work

Phase I Study in Advanced Cancer Patients of a Diversified Prime-and-Boost Vaccination Protocol Using Recombinant Vaccinia Virus and Recombinant Nonreplicating Avipox Virus to Elicit Anti–Carcinoembryonic Antigen Immune Responses

Year: 2000

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2000.18.23.3964

Authors: John L. Marshall, Robert J. Hoyer, Mary Ann Toomey, Kristen Faraguna, Ping Chang, Ellen Richmond, James E. Pedicano, Edmund Gehan, Ronald A. Peck, Philip Arlen, Kwong Y. Tsang, Jeffrey Schlom

Institutions: National Institutes of Health, Georgetown University Medical Center, National Cancer Institute, Georgetown Lombardi Comprehensive Cancer Center, University of Virginia

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1960833366

FWCI: 9.5

Cites: 27

Cited by: 356

Related to: 10